fumarates and Pseudomonas-Infections

fumarates has been researched along with Pseudomonas-Infections* in 1 studies

Other Studies

1 other study(ies) available for fumarates and Pseudomonas-Infections

Article	Year
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Bacterial persisters are a quasidormant subpopulation of cells that are tolerant to antibiotic treatment. The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aimed at reducing recurrent Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Fumarates; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin	2017

Article

Year

An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.

Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

Bacterial persisters are a quasidormant subpopulation of cells that are tolerant to antibiotic treatment. The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aimed at reducing recurrent

Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Fumarates; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin

2017